Key Metrics
Journal Specifications
- PublisherADIS INT LTD
- LanguageEnglish
- FrequencySemi-monthly
- LanguageEnglish
- FrequencySemi-monthly
- Publication Start Year1971
- Publisher URL
- Website URL
Topics Covered
Year-wise Publication
- 5Y
- 10Y
FAQs
Since when has Drugs been publishing? ![Faqs](assets/images/arrow-down.svg)
The Drugs has been publishing since 1971 till date.
How frequently is the Drugs published? ![Faqs](assets/images/arrow-down.svg)
Drugs is published Semi-monthly.
What is the H-index. SNIP score, Citescore and SJR of Drugs? ![Faqs](assets/images/arrow-down.svg)
Drugs has a H-index score of 179, Citescore of 16.3, SNIP score of 2.68, & SJR of Q1
Who is the publisher of Drugs? ![Faqs](assets/images/arrow-down.svg)
The publisher of Drugs is ADIS INT LTD.
How can I view the journal metrics of Drugs on editage? ![Faqs](assets/images/arrow-down.svg)
For the Drugs metrics, please refer to the section above on the page.
What is the eISSN and pISSN number of Drugs? ![Faqs](assets/images/arrow-down.svg)
The eISSN number is 1179-1950 and pISSN number is 0012-6667 for Drugs.
What is the focus of this journal? ![Faqs](assets/images/arrow-down.svg)
The journal covers a wide range of topics inlcuding Lung cancer, Multiple sclerosis, Body mass index, Breast cancer, Hemodialysis, Antipruritic Activity, Psoriatic arthritis, Spinal muscular atrophy, Type 2 diabetes, Lonafarnib, Gefitinib, Psoriasis, Immunotherapy, Migraine, Filgotinib, Clinical trial, Dexamethasone, Overall survival, Capsaicin, Fabry disease.
Why is it important to find the right journal for my research? ![Faqs](assets/images/arrow-down.svg)
Choosing the right journal ensures that your research reaches the most relevant audience, thereby maximizing its scholarly impact and contribution to the field.
Can the choice of journal affect my academic career? ![Faqs](assets/images/arrow-down.svg)
Absolutely. Publishing in reputable journals can enhance your academic profile, making you more competitive for grants, tenure, and other professional opportunities.
Is it advisable to target high-impact journals only? ![Faqs](assets/images/arrow-down.svg)
While high-impact journals offer greater visibility, they are often highly competitive. It's essential to balance the journal's impact factor with the likelihood of your work being accepted.